Delivery Order SPE2DB20D9331-SPE2DB22FL0M0
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,358.00, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $6,503.04, with a completion date of May 19, 2022. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of NARCAN 4 MG NASAL SPRAY 2S. The award, valued at $6,503.04, is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This IDC allows DLA to issue delivery orders...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,222.00 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, with a completion date of September 29, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
- This contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $1,625.76. The contract has an ultimate completion date of February 28, 2023. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,518.40, is for the supply of NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $7,333.20, was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order valued at $7,333.20, with an ultimate completion date of January 6, 2022. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The award is a firm fixed-price delivery order, with no set-aside designation, valued at $7,333.20. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the issuance of delivery orders for a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,438.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB22FL0M0Delivery Order
This federal contract award is for the delivery of 4556049371 units of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA) by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $16,296.00 and an ultimate completion date of January 26, 2022. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 1/25/22 |